Mira Pharmaceuticals Inc
NASDAQ:MIRA
Relative Value
The Relative Value of one MIRA stock under the Base Case scenario is hidden USD. Compared to the current market price of 1.23 USD, Mira Pharmaceuticals Inc is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
MIRA Competitors Multiples
Mira Pharmaceuticals Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
M
|
Mira Pharmaceuticals Inc
NASDAQ:MIRA
|
48.6m USD | 0 | -1.7 | -5.8 | -5.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
965.7B USD | 14.8 | 46.8 | 31.5 | 33.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
594B USD | 6.3 | 22.2 | 15.4 | 18.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
291.5B CHF | 4.8 | 31 | 13.1 | 15.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.4B GBP | 5.5 | 31.6 | 17.4 | 24.5 | |
| CH |
|
Novartis AG
SIX:NOVN
|
242.5B CHF | 5.5 | 22.3 | 13.8 | 17.7 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.7B USD | 4.7 | 16.6 | 10.4 | 12.2 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.4 | 13.3 | 9.7 | 11.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD | 2.4 | 19.6 | 7.3 | 9.8 | |
| UK |
|
GSK plc
XETRA:GS71
|
105.9B EUR | 2.8 | 16.1 | 8.1 | 11.5 |